Clinical trial
Intravenous Voriconazole in Patients With Renal Compromise
NCT00332410 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00332410 |
|---|---|
| Title | Intravenous Voriconazole in Patients With Renal Compromise |
| Official title | Intravenous Voriconazole in Patients With Renal Compromise |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Renal Transplant |
| Enrollment | 150 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Jun 1, 2006 |
| Last update posted | Jun 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: